What is NeoGenomics's change in accrued liabilities?

NeoGenomics (NEO) reported change in accrued liabilities of -$7M in Q1 2026.

How has NeoGenomics's change in accrued liabilities changed year-over-year?

NeoGenomics's change in accrued liabilities increased by 69.5% year-over-year, from -$22.96M to -$7M.

What does change in accrued liabilities mean?

Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.

NeoGenomics NEO Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Labcorp HoldingsLH

-$27.4M+84.3%

Personalis, Inc.PSNL

-$426K+84.5%

Natera, Inc.NTRA

$98.23M+477%

Tempus AI, Inc.TEM

$5.26M+119%

Opko HealthOPK

-$8.16M+57.9%

Agilent TechnologiesA

-$151M-45.2%

Other financials

Income statement

See full

Revenue$186.7M+11.1%

Gross profit$80.9M+10.4%

Operating income-$18.2M+34.4%

Net income-$17.1M+34.0%

EPS (diluted)-$0.13+35.0%

Balance sheet

See full

Cash & equivalents$146.1M-57.8%

Total debt$66.3M+5.3%

Total equity$828.8M-6.7%

Total assets$1.3B-15.9%

Cash flow

See full

Operating cash flow-$8.1M+67.9%

CapEx$5.0M+11.1%

Free cash flow-$13.1M+56.0%

Valuation

See full

Market cap$1.68B+86.5%

Enterprise value$1.6B+159%

P/S2.3×+0.9×

Profitability

See full

Gross margin43.2%-1.1pp

Operating margin-14.2%+1.1pp

Net margin-13.3%+2.4pp

FCF margin-4.9%—

Returns & leverage

See full

Return on equity-11.6%+6.2pp

Debt / equity0.1×0.0×

Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NeoGenomics's change in accrued liabilities?: NeoGenomics (NEO) reported change in accrued liabilities of -$7M in Q1 2026.
How has NeoGenomics's change in accrued liabilities changed year-over-year?: NeoGenomics's change in accrued liabilities increased by 69.5% year-over-year, from -$22.96M to -$7M.
What does change in accrued liabilities mean?: Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.